Skip to content

Preliminary Investigation of Novel Methods to Reduce Children's Secondhand Smoke Exposure

Novel Methods to Reduce Children's Secondhand Smoke Exposure I

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01935713
Acronym
EZI
Enrollment
89
Registered
2013-09-05
Start date
2012-04-30
Completion date
2012-12-31
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondhand Smoke

Brief summary

The overall aim of the current study is to determine if the use of nicotine containing products by caregivers who smoke and who are not interested in quitting, is effective in reducing children's secondhand smoke exposure.

Interventions

Participants were given the choice of 2mg or 4mg lozenges depending on how many cigarettes per day they reported to smoke.

DRUGElectronic Cigarette

Participants were given an e-cigarette starter kit, charging case, and cartridges in either 12mg or 16 mg nicotine, depending on their current amount of cigarettes smoked per day.

DRUGDissolvable Tobacco Lozenge

Participants were given Ariva (light to moderate smokers) or Stonewall (heavier smokers, \>2 packs per day).

Sponsors

University of Oklahoma
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

In order to be included in the study, participants must: 1. be the primary caregiver(defined as a person who spends the most time with the child and spends a minimum of 4 hours per day in the presence of the child) of a child between the ages of 3-11 (if caregiver has more \> 1 child between 3-11 years, we will include the youngest) 2. smoke at least 10 cigarettes per day for the past year 3. indicate that they smoke around their child or in the car or home at least one time per week\] 4. have no intention of quitting smoking in the next 12-weeks 5. aged 18-65 years 6. be fluent in English 7. have no recent history of cardiovascular distress that may contraindicate medicinal nicotine lozenge use (heart attack in the past year, arrhythmia, uncontrolled hypertension) 8. not currently pregnant, planning to become pregnant, or breastfeeding 9. do not use non-cigarette tobacco (cigars, chewing tobacco) 10. have no prior use of any potential reduced exposure product 11. have no major psychiatric impairment, including psychosis, suicidality, and/or any current alcohol/drug abuse or dependence

Exclusion criteria

* Does not meet all of the requirements of inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Change in child salivary cotinine2, 4, 8, and 12 weeksChild salivary cotinine will be measured to assess the level of secondhand smoke exposure. We will measure the change throughout the study.

Secondary

MeasureTime frameDescription
Change in Parent and Child Lung Function2, 4, 8, and 12 weeksWe will collect both parent and child spirometry data and compare changes.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026